Benzinga | Nov 16, 2020 04:08PM EST

Surgalign Holdings And Aziyo Biologics Announce Expanded Distribution Agreement

Updated agreement expands availability of ViBone(r) Moldable, a next generation moldable cellular bone matrix product

DEERFIELD, Ill. and SILVER SPRING, Md., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ:SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, and Aziyo Biologics, Inc. (NASDAQ:AZYO), a commercial-stage regenerative medicine company, today announced an updated distribution agreement and expanded product offering whereby Aziyo will provide ViBone(r) Moldable to Surgalign for distribution in the U.S. ViBone Moldable joins Surgalign's orthobiologic solutions to support spinal fusion, which currently include ViBone and other advanced bone graft solutions.